Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • ADVERTISEMENT FEATURE Advertiser retains sole responsibility for the content of this article

OncoQuest aims to enhance the success of cancer immunotherapy

This Canadian biotechnology company is developing combination-treatment strategies based on monoclonal antibodies to improve clinical outcomes for cancer patients.

Produced by

Nature Research Custom Media
OncoQuest Inc
Download PDF

Click the link on this page to download the full PDF

Search

Advanced search

Quick links